Connors Investor Services Inc. decreased its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 5.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,552 shares of the company’s stock after selling 1,225 shares during the period. Connors Investor Services Inc.’s holdings in Procter & Gamble were worth $3,274,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in the stock. Nova Wealth Management Inc. acquired a new stake in Procter & Gamble in the 1st quarter valued at approximately $26,000. Signature Resources Capital Management LLC increased its position in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares during the period. Quarry LP acquired a new position in shares of Procter & Gamble during the 1st quarter valued at $33,000. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at $34,000. Finally, RMG Wealth Management LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at $37,000. Institutional investors own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the transaction, the chief executive officer owned 61,764 shares of the company’s stock, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Balaji Purushothaman sold 490 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the transaction, the insider owned 12,616 shares of the company’s stock, valued at approximately $1,920,533.68. This trade represents a 3.74% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by company insiders.
Procter & Gamble Trading Up 0.3%
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s payout ratio is presently 64.98%.
Analysts Set New Price Targets
PG has been the subject of several research reports. Raymond James Financial reduced their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research note on Monday. Barclays lowered their price target on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. BNP Paribas reiterated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Wells Fargo & Company reduced their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Finally, BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $171.68.
Check Out Our Latest Stock Report on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- ESG Stocks, What Investors Should Know
- Breakout Momentum Plays You Need to Know About
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Quanta Services: The Backbone of the AI Data Center Push
- Overbought Stocks Explained: Should You Trade Them?
- Archer’s Recent String of Victories Signals a New Phase of Growth
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.